Longitudinal Associations between Concurrent Changes in Phenotypic Frailty and Lower Urinary Tract Symptoms among Older Men - 21/11/24

Doi : 10.14283/jfa.2022.33 
Scott R. Bauer 1, 2, 3, 10, ⁎ , C.E. McCulloch 4, P.M. Cawthon 4, 5, K.E. Ensrud 6, A.M. Suskind 2, J.C. Newman 7, 9, S.L. Harrison 5, A. Senders 8, K. Covinsky 3, 9, L.M. Marshall 8

Osteoporotic Fractures in Men (MrOS) Research Group

1 Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, CA, USA 
2 Department of Urology, University of California, San Francisco, CA, USA 
3 San Francisco VA Healthcare System, San Francisco, CA, USA 
4 Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA 
5 Research Institute, California Pacific Medical Center, San Francisco, CA, USA 
6 Department of Medicine and Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, USA 
7 Buck Institute for Research on Aging, Novato, CA, USA 
8 Oregon Health and Science University-Portland State University School of Public Health, Portland, OR, USA 
9 Division of Geriatrics, Department of Medicine, University of California, San Francisco, CA, USA 
10 Division of General Internal Medicine, SFVA Medical Center, 4150 Clement St., Building 2, Room 135, 94121, San Francisco, CA, USA 

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

Lower urinary tract symptoms (LUTS) are associated with prevalent frailty and functional impairment, but longitudinal associations remain unexplored.

Objectives

To assess the association of change in phenotypic frailty with concurrent worsening LUTS severity among older men without clinically significant LUTS at baseline.

Design

Multicenter, prospective cohort study.

Setting

Population-based.

Participants

Participants included community-dwelling men age ≥65 years at enrollment in the Osteoporotic Fractures in Men study.

Measurements

Data were collected at 4 visits over 7 years. Phenotypic frailty score (range: 0–5) was defined at each visit using adapted Fried criterion and men were categorized at baseline as robust (0), pre-frail (1–2), or frail (3–5). Within-person change in frailty was calculated at each visit as the absolute difference in number of criteria met compared to baseline. LUTS severity was defined using the American Urologic Association Symptom Index (AUASI; range: 0–35) and men with AUASI ≥8 at baseline were excluded. Linear mixed effects models were adjusted for demographics, health-behaviors, and comorbidities to quantify the association between within-person change in frailty and AUASI.

Results

Among 3235 men included in analysis, 48% were robust, 45% were pre-frail, and 7% were frail. Whereas baseline frailty status was not associated with change in LUTS severity, within-person increases in frailty were associated with greater LUTS severity (quadratic P<0.001). Among robust men at baseline, mean predicted AUASI during follow-up was 4.2 (95% CI 3.9, 4.5) among those meeting 0 frailty criteria, 4.6 (95% CI 4.3, 4.9) among those meeting 1 criterion increasing nonlinearly to 11.2 (95% CI 9.8, 12.6) among those meeting 5 criteria.

Conclusions

Greater phenotypic frailty was associated with nonlinear increases in LUTS severity in older men over time, independent of age and comorbidities. Results suggest LUTS and frailty share an underlying mechanism that is not targeted by existing LUTS interventions.

El texto completo de este artículo está disponible en PDF.

Key words : Aging, epidemiology, benign prostatic hyperplasia, sarcopenia


Esquema


 Sponsor’s Role: The study funders had no role in the design, methods, subject recruitment, data collections, analysis or preparation of this paper.
 Electronic Supplementary Material
Supplementary material is available for this article at jfa.2022.33 and is accessible for authorized users.


© 2022  THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 12 - N° 2

P. 117-125 - avril 2023 Regresar al número
Artículo precedente Artículo precedente
  • Optimizing the Aging Brain: The BEAD Study on the Ethics of Dementia Prevention
  • M. Andreoletti, C. Lazzaroni, N. Petersen, S. Segawa, A. Leibing, S. Schicktanz, Alessandro Blasimme
| Artículo siguiente Artículo siguiente
  • Assessing the Readiness for Implementing the World Health Organization’s ICOPE Approach in Hong Kong: Perspectives from Social Care and Policy Stakeholders
  • Ruby Yu, G. Leung, D. Lai, C. Tong, L.Y. Tam, C. Cheng, S. Kong, J. Woo

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.